NOV 10, 2020 6:04 PM PST

Nanoparticles Pass the Blood-Brain Barrier in Zebrafish

WRITTEN BY: Amanda Mikyska

Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain barrier. 

Researchers at Institut National de la Recherche Scientifique (INRS) in Quebec have tested new surface characteristics of nanoparticles, aiming to eventually deliver treatment for neurodegenerative diseases.  This is an important step toward treating neurodegenerative diseases like Alzheimer’s and Parkinson’s because current medical technology cannot deliver medication directly to the brain.  Medicine delivered via the blood is blocked by the blood-brain barrier, a strict filter that prevents harmful particles in the bloodstream from passing into the brain. 

Nanoparticles are already being used to treat some types of cancers, anemia, and neuroinflammation due to epilepsy.  These vehicles are small enough to pass through endothelial cells, which make up the blood-brain barrier, and deliver medicine directly to the brain.  However, the success rate of nanoparticles bypassing the blood-brain barrier needs to be improved.  

The researchers at INRS tested different surface attachments that endothelial cells might recognize, and allow passage of the nanoparticles into the brain where medicine will be released.  The attachments are made of polyethylene glycol (PEG) and come in an array of shapes and sizes.  They found that nanoparticles with longer PEG5000 attachments were more readily accepted by the filter than nanoparticles of the same size with shorted attachments.  

They also found that once in the brain, the nanoparticles did not widely distribute, a characteristic that needs to be studied for safety, and modulated to fit specific medical applications.  

This research was conducted on live zebrafish larvae which is a valuable model because zebrafish have a comparable blood-brain barrier to humans.  The next step is to test these surface attachments for safety and efficacy on a mammal model.  

 

Sources: Anselmo and Mitragotri, Rabanel et. al., ScienceDaily

 

 

 

About the Author
  • Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
AUG 25, 2020
Neuroscience
Study Shows Exercise Relieves Major Depression
AUG 25, 2020
Study Shows Exercise Relieves Major Depression
Depression is a common mental condition that many feel at some point throughout life. While antidepressants work for som ...
OCT 03, 2020
Neuroscience
Crows Have Conscious Thought, Just Like Primates
OCT 03, 2020
Crows Have Conscious Thought, Just Like Primates
Researchers from the University of Tubingen in Germany have found that crows are capable of conscious thought. They say ...
OCT 29, 2020
Clinical & Molecular DX
Skin Deep: A Novel Test for Parkinson's
OCT 29, 2020
Skin Deep: A Novel Test for Parkinson's
In Parkinson’s disease (PD), there is chronic degeneration of the central nervous system, particularly in the regi ...
NOV 01, 2020
Neuroscience
Depression Increases Risk of Having a Stroke
NOV 01, 2020
Depression Increases Risk of Having a Stroke
Researchers in Alabama have found that people who suffer from multiple depressive symptoms are at an increased risk of h ...
NOV 08, 2020
Neuroscience
Psychedelic DMT Improves Memory by Neurogenesis
NOV 08, 2020
Psychedelic DMT Improves Memory by Neurogenesis
Researchers from the Complutense University of Madrid in Spain have found that dimethyltryptamine (DMT), the psychoactiv ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
Loading Comments...